Amyris, Inc. (AMRS)


-0.01 (-21.88%)
Symbol AMRS
Price $0.05
Beta 1.189
Volume Avg. 23.76M
Market Cap 18.469M
Shares () -
52 Week Range 0.05-4.86
1y Target Est -
DCF Unlevered AMRS DCF ->
DCF Levered AMRS LDCF ->
ROE 136.68% Strong Buy
ROA -92.43% Strong Sell
Operating Margin -
Debt / Equity -155.71% Sell
P/E -0.04 Neutral
P/B -0.03 Neutral


Consensus EPS

Upgrades & Downgrades

Latest AMRS news

Mr. Hermanus Kieftenbeld
Basic Materials
Specialty Chemicals
NASDAQ Global Select

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.